Xinsuo M. Duan

No. 36 Nanyingzi Street
Xiabancheng, 067000, China

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 24 publications

SSGJ-608 in moderate-to-severe plaque psoriasis: a multicenter, randomized, open-label, phase 3 study.

SSGJ-608 in moderate-to-severe plaque psoriasis: a multicenter, randomized, open-label, phase 3 study.

Journal: Frontiers in immunology
Published: February 13, 2026

Safety and Efficacy of ICP-332 for Moderate to Severe Atopic Dermatitis: A Phase 2 Randomized Clinical Trial.

Safety and Efficacy of ICP-332 for Moderate to Severe Atopic Dermatitis: A Phase 2 Randomized Clinical Trial.

Journal: JAMA dermatology
Published: January 14, 2026

Efficacy and Safety of SSGJ-608 in Moderate-to-Severe Plaque Psoriasis: A Pivotal Multicenter, Double-Blind, Placebo-Controlled, Randomized, Phase III Clinical Trial.

Efficacy and Safety of SSGJ-608 in Moderate-to-Severe Plaque Psoriasis: A Pivotal Multicenter, Double-Blind, Placebo-Controlled, Randomized, Phase III Clinical Trial.

Journal: American journal of clinical dermatology
Published: January 13, 2026

Integrated transcriptomic and proteomic profiling in keloid tissue.

Integrated transcriptomic and proteomic profiling in keloid tissue.

Journal: PeerJ
Published: December 22, 2025

Novel TYK2 inhibitor D-2570 in moderate-to-severe plaque psoriasis: A randomized, double-blind, placebo-controlled, phase 2 trial.

Novel TYK2 inhibitor D-2570 in moderate-to-severe plaque psoriasis: A randomized, double-blind, placebo-controlled, phase 2 trial.

Journal: Journal of the American Academy of Dermatology
Published: July 08, 2025

Exploring drug-induced pemphigus findings from the FDA adverse event reporting system database.

Exploring drug-induced pemphigus findings from the FDA adverse event reporting system database.

Journal: Medicine
Published: June 03, 2025

Identification and Verification of SLC6A15 Involved in Keloid via Bioinformatics Analysis and Machine Learning.

Identification and Verification of SLC6A15 Involved in Keloid via Bioinformatics Analysis and Machine Learning.

Journal: Biochemical genetics
Published: April 10, 2025

Superior efficacy and comparable safety of calcipotriol plus betamethasone dipropionate foam vs. ointment in Chinese patients with plaque psoriasis: A randomized phase 3 trial.

Superior efficacy and comparable safety of calcipotriol plus betamethasone dipropionate foam vs. ointment in Chinese patients with plaque psoriasis: A randomized phase 3 trial.

Journal: Chinese medical journal
Published: March 21, 2025

Efficacy and safety of SYSA1902 versus reference ustekinumab in moderate-to-severe plaque psoriasis: A multicenter, randomized, phase III study.

Efficacy and safety of SYSA1902 versus reference ustekinumab in moderate-to-severe plaque psoriasis: A multicenter, randomized, phase III study.

Journal: Journal of the American Academy of Dermatology
Published: January 19, 2025

Efficacy and Safety of 611 in Chinese Adults with Moderate-to-Severe Atopic Dermatitis: Results from a Phase II Trial.

Efficacy and Safety of 611 in Chinese Adults with Moderate-to-Severe Atopic Dermatitis: Results from a Phase II Trial.

Journal: Dermatology and therapy
Published: December 05, 2024

Long non-coding RNA CYTOR promotes the progression of melanoma via the miR-485-5p/GPI axis.

Long non-coding RNA CYTOR promotes the progression of melanoma via the miR-485-5p/GPI axis.

Journal: PeerJ
Published: October 27, 2024

Antifungal resistance of the Trichophyton mentagrophytes/Trichophyton interdigitale species complex: Insights from the China Antifungal Resistance Dermatophytes Surveillance network Study (CARDS).

Antifungal resistance of the Trichophyton mentagrophytes/Trichophyton interdigitale species complex: Insights from the China Antifungal Resistance Dermatophytes Surveillance network Study (CARDS).

Journal: Journal of the European Academy of Dermatology and Venereology : JEADV
Published: October 20, 2024
Showing 1-12 of 24

Last Updated: 09/26/2026